Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD

Condition:   Peripheral Arterial Disease Interventions:   Drug: Rivaroxaban;   Drug: ASA Sponsors:   Poznan University of Medical Sciences;   Poznan University of Physical Education;   Institute of Human Genetics, Polish Academy of Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials